Cargando…
An update on the CNS manifestations of neurofibromatosis type 2
Neurofibromatosis type II (NF2) is a tumor predisposition syndrome characterized by the development of distinctive nervous system lesions. NF2 results from loss-of-function alterations in the NF2 gene on chromosome 22, with resultant dysfunction of its protein product merlin. NF2 is most commonly as...
Autores principales: | Coy, Shannon, Rashid, Rumana, Stemmer-Rachamimov, Anat, Santagata, Sandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7038792/ https://www.ncbi.nlm.nih.gov/pubmed/31161239 http://dx.doi.org/10.1007/s00401-019-02029-5 |
Ejemplares similares
-
Correction to: An update on the CNS manifestations of neurofibromatosis type 2
por: Coy, Shannon, et al.
Publicado: (2019) -
Transcriptomic signature of painful human neurofibromatosis type 2 schwannomas
por: Kukutla, Phanidhar, et al.
Publicado: (2021) -
Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2
por: Prabhakar, Shilpa, et al.
Publicado: (2022) -
Multiple synchronous sites of origin of vestibular schwannomas in neurofibromatosis Type 2
por: Stivaros, Stavros M, et al.
Publicado: (2015) -
Dermatologic Manifestations of Neurofibromatosis Type 1 and Emerging Treatments
por: Poplausky, Dina, et al.
Publicado: (2023)